CDC73 and pachyonychia congenita: Furthermore, evaluation regarding loss of parafibromin immunohistochemistry could be useful for diagnosis and differentiation of PC from other parathyroid lesions in daily practice, especially in cases with an initial suspicion of malignant potential to avoid excessive numbers of false positives [16–18].